Global Information
회사소개 | 문의

HCS(High Content Screening)/이미징 : 기술과 세계 시장

High Content Screening/Imaging: Technologies and Global Markets

리서치사 BCC Research
발행일 2018년 10월 상품 코드 733536
페이지 정보 영문 171 Pages
가격
US $ 5,500 ₩ 6,291,400 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,549,700 PDF by E-mail (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 9,059,600 PDF by E-mail (Site License)
US $ 9,504 ₩ 10,871,600 PDF by E-mail (Enterprise License)


HCS(High Content Screening)/이미징 : 기술과 세계 시장 High Content Screening/Imaging: Technologies and Global Markets
발행일 : 2018년 10월 페이지 정보 : 영문 171 Pages

세계 HCS(High Content Screening)/이미징 시장은 2018년 9억 1,500만 달러에서 2023년까지 17억 달러에 달할 것으로 예측되며, 2018-2023년간 13.1%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계의 HCS(High Content Screening)/이미징 시장에 대해 조사했으며, 시장 및 기술 개요, 시장 동향과 데이터 실적과 예측, 기술 발전 분석, 주요 기업 개요 등의 정보를 제공합니다.

제1장 서론

제2장 요약 및 하이라이트

제3장 시장 및 기술 배경

  • 현미경 및 이미징 기술 개요
  • 기술 진보
  • 프로세스 개요
  • 시장 역학

제4장 시장 분석 : 컴포넌트별

  • 기구 또는 플랫폼
  • 소모품(시약, 키트)
  • 소프트웨어 및 분석
  • 서비스

제5장 시장 분석 : 최종사용자별

  • 대학
  • 실험실 및 병리센터
  • 기업(바이오테크놀러지, 의약품, 임상시험수탁기관(CRO))

제6장 시장 분석 : 용도별

  • 분자진단
  • 종양
  • Drug Discovery
  • 독성연구
  • 신경과학
  • 화합물 프로파일링

제7장 시장 분석 : 지역별

  • 북미
  • 유럽
  • MEA(중동 및 아프리카)
  • 아시아태평양
  • 기타

제8장 특허 리뷰

제9장 산업 구조

  • 제조업체/공급업체
    • Thermo Fisher Scientific
    • GE Healthcare
    • Olympus
    • Molecular Devices
    • PerkinElmer, Inc.

제10장 기업 개요

  • ALBANY MOLECULAR RESEARCH, INC.(AMRI)
  • AURELIA BIOSCIENCE LTD.
  • AXXAM SPA
  • BECTON, DICKINSON AND CO.
  • BIOTEK INSTRUMENTS, INC.
  • CHARLES RIVER
  • CORNING, INC.
  • CREATIVE BIOLABS
  • CURIOX BIOSYSTEMS, INC.
  • CYTOO SA
  • DANAHER CORP.
  • DE NOVO SOFTWARE
  • DEFINIENS AG
  • DISCOVERX CORP.
  • ESSEN BIOSCIENCE
  • EVOTEC AG
  • FLUXION BIOSCIENCES
  • GE HEALTHCARE
  • GENEDATA AG
  • HUDSON ROBOTICS, INC.
  • INSTRUMENT SYSTEMS
  • INTELLICYT CORP.
  • LUMENCOR, INC.
  • MERCK MILLIPORE
  • MOLECULAR DEVICES
  • NEMAMETRIX, INC.
  • NIKON INSTRUMENTS, INC.
  • Olympus
  • PERKINELMER, INC.
  • PHENOVISTA BIOSCIENCES LLC
  • PLATYPUS TECHNOLOGIES
  • SYSMEX CORP.
  • TECAN GROUP LTD.
  • THERMO FISHER SCIENTIFIC, INC.
  • THORLABS, INC.
  • VALA SCIENCES, INC.
  • YOKOGAWA ELECTRIC CORP.
  • ZEISS GROUP
LSH 18.11.08

List of Tables

  • Summary Table: Global Market for High Content Screening/Imaging, by Component, Through 2023
    • Table 1: Microscopes Used in HCS/I
    • Table 2: HTS Detection Methods
    • Table 3: HTS Product Portfolios
    • Table 4: Comparison of Cellomics with Other Omics Techniques
    • Table 5: Comparison of HCS Microscopes
    • Table 6: Global Market for HCS/I, by Component, Through 2023
    • Table 7: Global Market for HCS/I, by Instrument/Platform, Through 2023
    • Table 8: Global Market for Instruments/Platforms, by Region, Through 2023
    • Table 9: HCS Platforms, by Thermo Fisher Scientific
    • Table 10: Cytometers
    • Table 11: Microplate Readers Available in the Market and Their Manufacturers
    • Table 12: Fluorescent Dyes Used for the Sensor Array
    • Table 13: Automated Liquid Handling Modules
    • Table 14: Global Market for Consumables, by Region, Through 2023
    • Table 15: Specification of HCS Live/Dead Green Kit
    • Table 16: Global Market for Software and Analytics, by Region, Through 2023
    • Table 17: Global Market for Services, by Region, Through 2023
    • Table 18: Global Market for HCS/I, by End User, Through 2023
    • Table 19: Global Market for HCS/I in Academics, by Region, Through 2023
    • Table 20: Institutes with HCS Facilities
    • Table 21: Global Market for HCS/I in Laboratories and Pathology Centers, by Region, Through 2023
    • Table 22: Global Market for HCS/I Used by Companies, by Region, Through 2023
    • Table 23: Global Market for HCS/I, by Application, Through 2023
    • Table 24: Global Market for HCS/I, by Region, Through 2023
    • Table 25: Global Market for HCS/I in Molecular Diagnostics, by Region, Through 2023
    • Table 26: Global Market for HCS/I in Oncology, by Region, Through 2023
    • Table 27: Global Market for HCS/I in Drug Discovery, by Region, Through 2023
    • Table 28: Evotec Products in Development for Cancer in Various Stages of Research
    • Table 29: Global Market for HCS/I in Toxicity, by Region, Through 2023
    • Table 30: Global Market for HCS/I in Neuroscience, by Region, Through 2023
    • Table 31: Global Market for HCS/I in Compound Profiling, by Region, Through 2023
    • Table 32: North American Market for HCS/I, by Country, Through 2023
    • Table 33: North American Market for HCS/I, by Component, Through 2023
    • Table 34: North American Market for HCS/I, by End User, Through 2023
    • Table 35: North American Market for HCS/I, by Application, Through 2023
    • Table 36: Total Pharma Business R&D Expenditures in Canada, 2011-2015
    • Table 37: European Market for HCS/I, by Country, Through 2023
    • Table 38: European Market for HCS/I, by Component, Through 2023
    • Table 39: European Market for HCS/I, by End User, Through 2023
    • Table 40: European Market for HCS/I, by Application, Through 2023
    • Table 41: Asia-Pacific Market for HCS/I, by Country, Through 2023
    • Table 42: Asia-Pacific Market for HCS/I, by Component, Through 2023
    • Table 43: Asia-Pacific Market for HCS/I, by End User, Through 2023
    • Table 44: Asia-Pacific Market for HCS/I, by Application, Through 2023
    • Table 45: Vaccine Manufacturers in India
    • Table 46: ROW Market for HCS/I, by Component, Through 2023
    • Table 47: ROW Market for HCS/I, by End User, Through 2023
    • Table 48: ROW Market for HCS/I, by Application, Through 2023
    • Table 49: Number of Patents Issued, by Key Company/Assignee, January 2015, Through 2017
    • Table 50: Number of Patents Issued, by Category, 2015-2017
    • Table 51: Number of Patents Issued, by Country, 2015-2017
    • Table 52: Number of Patents Issued, by Publication Year, 2015-2017
    • Table 53: Patents Issued, January 2015-December 2017
    • Table 54: Thermo Fisher Scientific Products Covered One or More Patents
    • Table 55: GE Healthcare Patents, 2015-2017
    • Table 56: Molecular Devices Patents, 2015-2017
    • Table 57: Recent Collaborations in the HCS Market, January 2016-February 2018
    • Table 58: Recent Product Launches in the HCS Market, April 2015-March 2018
    • Table 59: Major Partnerships in the HCS Market, 2017
    • Table 60: Major Mergers and Acquisitions in the HCS Market, 2017

List of Figures

  • Summary Figure: Global Market for High Content Screening/Imaging, by Component, 2017-2023
    • Figure 1: Approaches for Imaging Sample Surfaces
    • Figure 2: HCS in Drug Discovery
    • Figure 3: Four Steps of Data Analysis
    • Figure 4: Basic Tools for High Content Screening
    • Figure 5: Advantages of HTS
    • Figure 6: Application of High-Throughput Screening
    • Figure 7: Software Utilized for Data Analysis
    • Figure 8: Flow of Funding for Disease Research, 2014-2016
    • Figure 9: Investments, by Funding Category, 2016
    • Figure 10: Technological Advancements in HCS
    • Figure 11: Per Capita Healthcare Expenditures, 2016
    • Figure 12: GDP Growth Rate of India and China, 2013-2016
    • Figure 13: Key Benefits of Vectra Polaris Imaging Device
    • Figure 14: Five Main Components of a Flow Cytometer
    • Figure 15: Microplate Reader Categories
    • Figure 16: Features of ThiolTracker Violet
    • Figure 17: Features of HCS Studio 2.0 Cell Analysis Software
    • Figure 18: Features of Store Image and Database Management Software
    • Figure 19: Key Features of OpenHiCAMM
    • Figure 20: OpenHiCAMM: High Content Screening Software for Complex Microscope Imaging Workflows
    • Figure 21: Analysis of a Fluorescent Cellular Assay
    • Figure 22: Some of the Companies Contributing to Research and Drug Discovery
    • Figure 23: Incidence of Cancer in the U.S., 2017
    • Figure 24: Drug Discovery Cycle
    • Figure 25: Features of the Lead Compound
    • Figure 26: Timeline of Drug Discovery and Development
    • Figure 27: Types of Toxicity Studies
    • Figure 28: Percentage of New Cases by Age Group: Brain and Other Nervous System Cancers
    • Figure 29: Strategies to Improve Screening Using Compound Profiling
    • Figure 30: Gross Domestic Spending on R&D in North American Countries, 2016
    • Figure 31: U.S. Cancer Cases in Females, 2012
    • Figure 32: U.S. Cancer Cases in Males, 2012
    • Figure 33: Healthcare Expenditures for R&D, by U.S. State, 2016
    • Figure 34: Prevalence of Viral Hepatitis in the U.S., 2015
    • Figure 35: Gross Domestic Spending on Healthcare R&D in Canada, 2015 and 2016
    • Figure 36: Leading Causes of Death in Canada, 2017
    • Figure 37: Distribution of Projected Cancer Cases in Canada, by Type, 2017
    • Figure 38: European Union Investments in R&D Funding for Neglected Diseases, 2013-2016
    • Figure 39: Mortality from Cancer in the U.K., 2011-2017
    • Figure 40: U.K. Investments in R&D Funding for Neglected Diseases 2013-2016
    • Figure 41: Cancer Mortality in Germany, 2011-2017
    • Figure 42: Germany's Spending on Neglected Diseases, 2013-2016
    • Figure 43: Cancer Mortality in France, 2011-2017
    • Figure 44: Products in Development, by Therapeutic Application, 2016
    • Figure 45: French Spending on Neglected Diseases, 2013-2016
    • Figure 46: Cancer Mortality in Spain, 2011-2017
    • Figure 47: Spain's Spending on Neglected Diseases, 2013-2016
    • Figure 48: Cancer Mortality in Italy, 2011-2017
    • Figure 49: European Countries with High Cancer Mortality, 2014
    • Figure 50: Healthcare Expenditures in India
    • Figure 51: Healthcare Expenditures in China, 2016
    • Figure 52: Industry Structure of the High Content Screening Market
    • Figure 53: Strategies Adopted, by Key Market Players

Report Highlights:

The global market for high content screening/imaging should grow from $915.0 million in 2018 to reach $1.7 billion by 2023 at a compound annual growth rate (CAGR) of 13.1% for the period of 2018-2023.

Instrument or platform as a segment of high content screening/imaging should grow from $630.0 million in 2018 to reach $1.1 billion by 2023 at a CAGR of 12.2% for the period of 2018-2023.

Software and analytics as a segment of high content screening/imaging should grow from $70.0 million in 2018 to reach $151.0 million by 2023 at a CAGR of 16.6% for the period of 2018-2023.

Report Scope:

The HCS/I market has significant potential due to rising demand from the drug discovery and molecular diagnosis segments. The capabilities and possibilities of HCS/I market growth increases with the growth of new technologies and technological advancements. Emerging economies such as China, India, and South Korea are considered to be lucrative regions that are creating ample opportunities and scope for the market. Investments and funding from government and private ventures, research institutes and universities are supporting exploration into the potential of this market. Growing drug discovery and molecular diagnostic and research through HCS/I will further boost the market in the near future. The global rise in infectious and noninfectious diseases, growing populations, technological advancements and innovation are other factors creating considerable demand for HCS/I.

The scope of this study encompasses the current market for drug discovery, molecular diagnostics, cancer research, personalized medicine and compound profiling. The report also includes regulatory aspects, recent developments, market projections, competitive landscapes and market share. Analyses of patents, clinical trials, innovations and opportunities, as well as the latest trends, are also discussed in the report. The report intends to explain the key trends of HCS/I technologies and applications in various geographies. It also discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for government organizations, researchers, private players, angel investors, potential entrants and so forth.

Report Includes:

  • 38 data tables and 23 additional tables
  • An overview of the global markets for high content screening/imaging technologies
  • Analyses of global market trends, with data from 2017, estimated from 2018 and projections of compound annual growth rates (CAGRs) through 2023
  • Coverage of various microscope and imaging technologies in the industry
  • Detailed analysis of the technological advancement in cytometers, light sources, detectors/sensors and liquid handling instruments
  • Discussion of the various market motivators i.e. increasing R&D budget, advantages over manual and HTS, technological advancement, and automation
  • Company profiles of major players in the industry, including Albany Molecular Research, Inc. (AMRI), Cell Signaling Technology, Danaher Corp., GE Healthcare and Instrument Systems

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Information Sources
  • Research Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Overview of Microscope and Imaging Technologies
    • Scanning Probe Microscopy
    • Scanning Electron Microscope
    • Transmission Electron Microscopy
  • Technological Advancements
    • Cytometers
    • Detectors/Sensors
    • Liquid Handling Instruments
  • Process Overview
    • High Content Screening
    • High Throughput Screening (HTS)
  • Market Dynamics
    • Key Factors Driving the Market
    • Limitations and Challenges
    • Market Opportunities

Chapter 4: Market Breakdown by Component

  • Instrument or Platform
    • Imaging Device
    • Cytometers
    • Plate Reader
    • Light Sources
    • Detectors/Sensors
    • Liquid Handling Instruments
  • Consumables (Reagents and Kits)
  • Software and Analytics
    • Store Image and Database Management Software by Thermo Fisher Scientific
    • OpenHiCAMM (Open Hi Content Acquisition for μManager) Software
  • Services
    • siRNA Screens

Chapter 5: Market Breakdown by End User

  • Academics
  • Laboratories and Pathology Centers
  • Companies (Biotechnology, Pharmaceutical and CRO)

Chapter 6: Market Breakdown by Application

  • Molecular Diagnosis
  • Oncology
  • Drug Discovery
  • Toxicity Studies
    • Acute Toxicity Studies
    • Subchronic Toxicity Studies
    • Chronic Toxicity
  • Neuroscience
  • Compound Profiling

Chapter 7: Market Breakdown by Region

  • North America
    • United States
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • MEA (Middle East and Africa)
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Rest of the World

Chapter 8: Patent Review

Chapter 9: Industry Structure

  • Manufacturers/Suppliers
    • Thermo Fisher Scientific
    • GE Healthcare
    • GE Healthcare Patents, 2015-2017
    • Olympus Corp.
    • Molecular Devices
    • PerkinElmer, Inc.

Chapter 10: Company Profiles

  • ALBANY MOLECULAR RESEARCH, INC. (AMRI)
  • AURELIA BIOSCIENCE LTD.
  • AXXAM SPA
  • BECTON, DICKINSON AND CO.
  • BIOTEK INSTRUMENTS, INC.
  • CHARLES RIVER
  • CORNING, INC.
  • CREATIVE BIOLABS
  • CURIOX BIOSYSTEMS, INC.
  • CYTOO SA
  • DANAHER CORP.
  • DE NOVO SOFTWARE
  • DEFINIENS AG
  • DISCOVERX CORP.
  • ESSEN BIOSCIENCE
  • EVOTEC AG
  • FLUXION BIOSCIENCES
  • GE HEALTHCARE
  • GENEDATA AG
  • HUDSON ROBOTICS, INC.
  • INSTRUMENT SYSTEMS
  • INTELLICYT CORP.
  • LUMENCOR, INC.
  • MERCK MILLIPORE
  • MOLECULAR DEVICES
  • NEMAMETRIX, INC.
  • NIKON INSTRUMENTS, INC.
  • OLYMPUS CORP.
  • PERKINELMER, INC.
  • PHENOVISTA BIOSCIENCES LLC
  • PLATYPUS TECHNOLOGIES
  • SYSMEX CORP.
  • TECAN GROUP LTD.
  • THERMO FISHER SCIENTIFIC, INC.
  • THORLABS, INC.
  • VALA SCIENCES, INC.
  • YOKOGAWA ELECTRIC CORP.
  • ZEISS GROUP
Back to Top
전화 문의
이용안내
 
BCC Research